Where does Icahn School OF Medicine AT Mount Sinai rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Icahn School OF Medicine AT Mount Sinai ranks #1,685 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Icahn School OF Medicine AT Mount Sinai hold?

Icahn School OF Medicine AT Mount Sinai holds 244 US utility patents granted between 2015 and 2025, spanning 49 technology areas.

What is Icahn School OF Medicine AT Mount Sinai's Innovation Score?

Icahn School OF Medicine AT Mount Sinai has an Innovation Score of 61.6 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Icahn School OF Medicine AT Mount Sinai focus on?

Icahn School OF Medicine AT Mount Sinai's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 158 patents, ranking #109 of 7,163 assignees active in that subclass. Grants appear in 49 CPC subclasses total.

Is Icahn School OF Medicine AT Mount Sinai's patent grant rate increasing or decreasing?

Icahn School OF Medicine AT Mount Sinai's recent grant velocity is +7% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Icahn School OF Medicine AT Mount Sinai's patents?

Icahn School OF Medicine AT Mount Sinai's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Icahn School OF Medicine AT Mount Sinai patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Icahn School OF Medicine AT Mount Sinai

USPTO PatentsView assignee record - 244 granted patents across 49 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Icahn ranks #1,685 of 49,997 tracked US assignees by granted-patent volume, with 244 patents across 49 technology areas.

#1,685
of 49,997 US assignees by volume: Top 3%
by Innovation Score (61.6/100): 18.8
avg claims per patent: +7%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1685 · US Corporation #1,685 · 244 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MID 244 grants
TOP-DECILE #1,685/49,997
PHOTO-FINISH Airbus Defence AND…
CPC-WIDE A61K · 49 areas
INNOV-STRONG 61.6/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +7% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Airbus Defence AND Space SAS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Icahn’s 61.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 19.0 pts (31%) Velocity 6.6 pts (11%) Breadth 24.7 pts (40%) Claim depth 11.3 pts (18%)

Qualcomm Incorporated · highest

85
Volvo Construction… · near

62
Dupont · near

62
Icahn School OF… · this assignee

62
R J Reynolds Tobacco · near

62
Sick · near

62
3D Lighting… · lowest

7

What this shows Icahn's Innovation Score is 61.6/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Icahn?

Each dot is one of Icahn’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Icahn’s own 18.8 claims/patent is ABOVE the 16.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Icahn vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Icahn's grants concentrate

Icahn School OF Medicine AT Mount Sinai is a focused PatentsView assignee: 49 CPC subclasses with 64.8% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (29 grants) versus a trough of 16 in 2015. By volume, Icahn sits between Telecom Italia S.p.A. and Umicore AG & Co. KG.

Icahn's three-year grant acceleration

From 2019–2021 to 2022–2024, Icahn School OF Medicine AT Mount Sinai moved from 70 to 69 grants (0.99x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,221. See the growth leaderboard.

Telecom Italia S…

245
The Mitre

245
Airbus Defence AN…

244
Beckman Coulter

244
LG Hausys

244
Prysmian S p A

244
Spreadtrum Commun…

244
Umicore & KG

244
Icahn School OF M… ◀

244

What this shows Icahn holds 244 patents at rank #1,685, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Icahn

By rank, the assignees closest to #1,685 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Icahn's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Icahn, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Icahn ranks #109 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (62 here).

R.J. Reynolds Tobacco Company 62 Sick AG 62 Dupont Electronics, Inc. 62 Volvo Construction Equipment AB 62

Similar claim depth

Nearest assignees by average claims per patent (18.8 here).

Stripe, Inc. 18.8 avg Immatics Biotechnologies GmbH 18.8 avg Swagelok Company 18.8 avg Motorola Mobility LLC 18.8 avg

Icahn's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Icahn School OF Medicine AT Mount Sinai patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	16	6.6%
2016	17	7.0%
2017	21	8.6%
2018	26	10.7%
2019	26	10.7%
2020	17	7.0%
2021	27	11.1%
2022	29	11.9%
2023	19	7.8%
2024	21	8.6%
2025partial year	25	10.2%

Which technologies does Icahn School OF Medicine AT Mount Sinai patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 158

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 142

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 89

C07K - Peptides 68

C07D - Heterocyclic Compounds 39

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 36

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 25

C12Y - Enzymes 24

A61B - DIAGNOSIS; SURGERY; Identification 21

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 12

Y02A - Technologies FOR Adaptation TO Climate Change 11

G06F - Electric Digital Data Processing 9

C07C - Acyclic OR Carbocyclic Compounds 8

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 7

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

Top 15 of 49 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Icahn School OF Medicine AT Mount Sinai's patent record in context - here's where to go next.

Icahn School OF Medicine AT Mount Sinai's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 64.8% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #1,685 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Icahn School OF Medicine AT Mount Sinai against Telecom Italia S.p.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 61.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.